951 related articles for article (PubMed ID: 25368253)
41. RALY RNA binding protein-like reduced expression is associated with poor prognosis in clear cell renal cell carcinoma.
Cui ZW; Xia Y; Ye YW; Jiang ZM; Wang YD; Wu JT; Sun L; Zhao J; Fa PP; Sun XJ; Gui YT; Cai ZM
Asian Pac J Cancer Prev; 2012; 13(7):3403-8. PubMed ID: 22994768
[TBL] [Abstract][Full Text] [Related]
42. Loss of caspase 7 expression is associated with poor prognosis in renal cell carcinoma clear cell subtype.
Vilella-Arias SA; Rocha RM; da Costa WH; Zequi Sde C; Guimarães GC; Verjovski-Almeida S; Soares FA; Reis EM
Urology; 2013 Oct; 82(4):974.e1-7. PubMed ID: 23920448
[TBL] [Abstract][Full Text] [Related]
43. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.
Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J
Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266
[TBL] [Abstract][Full Text] [Related]
44. Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer.
Yang FQ; Yang FP; Li W; Liu M; Wang GC; Che JP; Huang JH; Zheng JH
Int J Clin Exp Pathol; 2014; 7(1):110-22. PubMed ID: 24427331
[TBL] [Abstract][Full Text] [Related]
45. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
[TBL] [Abstract][Full Text] [Related]
46. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
[TBL] [Abstract][Full Text] [Related]
47. Decreased expression of Dkk1 and Dkk3 in human clear cell renal cell carcinoma.
Guo CC; Zhang XL; Yang B; Geng J; Peng B; Zheng JH
Mol Med Rep; 2014 Jun; 9(6):2367-73. PubMed ID: 24676838
[TBL] [Abstract][Full Text] [Related]
48. Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma.
Ha YS; Lee GT; Modi P; Kwon YS; Ahn H; Kim WJ; Kim IY
J Urol; 2015 Nov; 194(5):1441-8. PubMed ID: 25796113
[TBL] [Abstract][Full Text] [Related]
49. Expression and significance of FOXP1, HIF-1a and VEGF in renal clear cell carcinoma.
Wan L; Huang J; Chen J; Wang R; Dong C; Lu S; Wu X
J BUON; 2015; 20(1):188-95. PubMed ID: 25778315
[TBL] [Abstract][Full Text] [Related]
50. High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Liu W; Liu Y; Fu Q; Xu J
Cancer Sci; 2015 May; 106(5):592-7. PubMed ID: 25702890
[TBL] [Abstract][Full Text] [Related]
51. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
Qi C; Ma H; Zhang HT; Gao JD; Xu Y
Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
[TBL] [Abstract][Full Text] [Related]
52. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
53. High Expression of Colony-Stimulating Factor 1 Receptor Associates with Unfavorable Cancer-Specific Survival of Patients with Clear Cell Renal Cell Carcinoma.
Yang L; Liu Y; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
Ann Surg Oncol; 2016 Mar; 23(3):1044-52. PubMed ID: 26467457
[TBL] [Abstract][Full Text] [Related]
54. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma.
Shinmei S; Sakamoto N; Goto K; Sentani K; Anami K; Hayashi T; Teishima J; Matsubara A; Oue N; Kitadai Y; Yasui W
Int J Urol; 2013 May; 20(5):468-77. PubMed ID: 23050614
[TBL] [Abstract][Full Text] [Related]
56. The expression and clinical significance of TGF-beta1 and MMP2 in human renal clear cell carcinoma.
Yang SD; Sun RC; Mu HJ; Xu ZQ; Zhou ZY
Int J Surg Pathol; 2010 Apr; 18(2):85-93. PubMed ID: 19223381
[TBL] [Abstract][Full Text] [Related]
57. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
58. Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer.
Dahinden C; Ingold B; Wild P; Boysen G; Luu VD; Montani M; Kristiansen G; Sulser T; Bühlmann P; Moch H; Schraml P
Clin Cancer Res; 2010 Jan; 16(1):88-98. PubMed ID: 20028743
[TBL] [Abstract][Full Text] [Related]
59. Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion.
Ma JJ; Kong LM; Liao CG; Jiang X; Wang Y; Bao TY
Med Oncol; 2012 Dec; 29(5):3306-13. PubMed ID: 22692967
[TBL] [Abstract][Full Text] [Related]
60. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
